Abstract
Bioluminescence resonance energy transfer (BRET) is a cutting-edge biophysical technique used for exploring G protein-coupled receptor (GPCR) pharmacology. BRET relies on the nonradiative energy transfer from a luciferase energy donor to an acceptor fluorophore after oxidation of a luciferase substrate. This energy transfer occurs only if the donor and acceptor are within close proximity. Over the past few years, BRET has been successfully applied to study GPCR oligomerization as well as interactions of receptors with G proteins, G protein-coupled receptor kinases (GRKs), or β-arrestins. Herein, we describe how BRET can be applied to study signaling at the oxytocin receptor (OTR) and vasopressin receptors, thereby enabling the identification of (biased) ligands and molecular probes for investigating receptor functionality.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stoddart LA, Johnstone EKM, Wheal AJ et al (2015) Application of BRET to monitor ligand binding to GPCRs. Nat Methods 12(7):661–663
Alcobia DC, Ziegler AI, Kondrashov A et al (2018) Visualizing ligand binding to a GPCR in vivo using NanoBRET. iScience 6:280–288
Okashah N, Wan Q, Ghosh S et al (2019) Variable G protein determinants of GPCR coupling selectivity. Proc Natl Acad Sci U S A 116(24):12054–12059
Pfleger KD, Eidne KA (2006) Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3(3):165–174
Pfleger KD, Seeber RM, Eidne KA (2006) Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protoc 1(1):337–345
Kocan M, See HB, Seeber RM et al (2008) Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein-coupled receptors in live cells. J Biomol Screen 13(9):888–898
Englebretsen DR, Harding DR (1992) Solid phase peptide synthesis on hydrophilic supports. Part II--studies using Perloza beaded cellulose. Int J Pept Protein Res 40(6):487–496
Pfleger KD, Dromey JR, Dalrymple MB et al (2006) Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal 18(10):1664–1670
Machleidt T, Woodroofe CC, Schwinn MK et al (2015) NanoBRET--A novel BRET platform for the analysis of protein-protein interactions. ACS Chem Biol 10(8):1797–1804
Stoddart LA, Kilpatrick LE, Hill SJ (2018) NanoBRET approaches to study ligand binding to GPCRs and RTKs. Trends Pharmacol Sci 39(2):136–147
Dale NC, Johnstone EKM, White CW et al (2019) NanoBRET: the bright future of proximity-based assays. Front Bioeng Biotechnol 7:56
Terrillon S, Durroux T, Mouillac B et al (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17(4):677–691
Wrzal PK, Devost D, Petrin D et al (2012) Allosteric interactions between the oxytocin receptor and the beta2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization. Cell Signal 24(1):342–350
Romero-Fernandez W, Borroto-Escuela DO, Agnati LF et al (2013) Evidence for the existence of dopamine D2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor-receptor interactions. Mol Psychiatry 18(8):849–850
Hasbi A, Devost D, Laporte SA et al (2004) Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Mol Endocrinol 18(5):1277–1286
Smith JS, Lefkowitz RJ, Rajagopal S (2018) Biased signalling: from simple switches to allosteric microprocessors. Nat Rev Drug Discov 17(4):243–260
Whalen EJ, Rajagopal S, Lefkowitz RJ (2011) Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med 17(3):126–139
Busnelli M, Sauliere A, Manning M et al (2012) Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J Biol Chem 287(6):3617–3629
Duerrauer L, Muratspahić E, Gattringer J et al (2019) I8-arachnotocin–an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptor. Sci Rep 9(1):19295
Kocan M, See HB, Sampaio NG et al (2009) Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol Endocrinol 23(4):559–571
Namkung Y, Le Gouill C, Lukashova V et al (2016) Monitoring G protein-coupled receptor and beta-arrestin trafficking in live cells using enhanced bystander BRET. Nat Commun 7:12178
Rajagopal S, Ahn S, Rominger DH et al (2011) Quantifying ligand bias at seven-transmembrane receptors. Mol Pharmacol 80(3):367–377
Kenakin T, Christopoulos A (2013) Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 12(3):205–216
Parreiras-e-Silva LT, Vargas-Pinilla P, Duarte DA et al (2017) Functional New World monkey oxytocin forms elicit an altered signaling profile and promotes parental care in rats. Proc Natl Acad Sci U S A 114(34):9044–9049
Acknowledgments
Edin Muratspahić and Jasmin Gattringer contributed equally to this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Muratspahić, E., Gattringer, J., Gruber, C.W. (2022). Use of BRET to Measure β-Arrestin Recruitment at Oxytocin and Vasopressin Receptors. In: Werry, E.L., Reekie, T.A., Kassiou, M. (eds) Oxytocin. Methods in Molecular Biology, vol 2384. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1759-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1759-5_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1758-8
Online ISBN: 978-1-0716-1759-5
eBook Packages: Springer Protocols